Chemoattractants such as IP-10 and MCP-1 have been reported to be up-regulated by TB treatments in mice, and pro-inflammatory cytokines including IFN-γ, TNFα, IL-12, IL-17 and IL-1β are associated with TB disease. Here, IL17A is linked to tuberculosis.